- Home
- Life Sciences
- Hematology
Hematology Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.
-
Published date -30th Jan 2024
-
Formats -PDF, CSV
-
Region -Global
Hematology Market Analysis
1. Market Size & CAGR of Hematology Market in 2021
The global hematology market had a market size of USD 55.7 billion in 2021 with a CAGR of 6.3%.
2. COVID-19 Impact on the Hematology Market
The COVID-19 pandemic has had a significant impact on the hematology market. Due to the pandemic, there was disruption in the supply chain of hematology products, leading to a temporary decline in market growth.
3. Hematology Dynamics
The hematology market is driven by factors such as increasing prevalence of blood disorders, growing demand for advanced diagnostics, and rising investments in research and development.
4. Segments and Related Analysis
The hematology market is segmented based on products (analyzers, reagents), applications (anemia, leukemia, lymphoma), and end-users (hospitals, diagnostic centers).
5. By Region Analysis
Regionally, North America dominated the hematology market in 2021, followed by Europe and Asia Pacific. The market is expected to witness significant growth in emerging economies.
6. Key Market Players and Competitive Landscape
Key market players in the hematology market include Sysmex Corporation, Abbott Laboratories, Roche Diagnostics, Beckman Coulter, and Siemens Healthcare.
7. Recent Happenings in the Hematology Market
In recent developments, Sysmex Corporation launched a new hematology analyzer with advanced features, and Abbott Laboratories introduced a novel diagnostic test for hemoglobin disorders.
